News & Events

Read about the latest Gore news and events. Learn about innovative new products and technologies.


COVID-19: Our Current Path Forward

Posted May 11, 2020

We are committed to doing what is right for our Associates and the customers and communities who rely on our products. Read a message from Gore’s Enterprise Leadership Team to learn more about our efforts.

Press Release

GORE® STA-PURE Flexible Freeze Container Receives Medicine Maker Innovation Award

Posted April 12, 2020

GORE® STA-PURE Flexible Freeze Containers' patented design was engineered to maximize container strength while the high-purity, biocompatible fluoropolymer composite film was selected for its durability and low extractables profile. The choice of Gore as one of the winners was based on it's potential impact on the industry. Drug manufacturers now have a high purity option for bulk drug storage that won't become brittle and potentially break or leak in use.

Press Release

Gore introduces new 9.0mL Protein Capture Device for affinity chromatography

Posted March 20, 2020

Gore is adding to it's range of affinity chromatography devices with the larger 9.0 mL size device for applications in process development, pre-clinical and early clinical drug development. This launch is significant because it demonstrates that this innovative membrane technology can be scaled to larger sizes without losing performance benefits.


Gore at AsiaTIDES 2020

February 24, 2020 - February 26, 2020

Visit Gore at AsiaTIDES 2020 in Kyoto Japan February 24-26, Stand 18 at the Westin Miyako Kyoto


Gore at IQPC Disposable Solutions for Biomanufacturing Global Conference

February 18, 2020 - February 20, 2020

Visit Gore at the IQPC Disposable Solutions for Biomanufacturing Global Conference 18-20 February 2020 at the Leonardo Royal Hotel Berlin Alexanderplatz in Berlin, Germany. 


Gore at Pharmapack 2020

February 5, 2020 - February 6, 2020

Visit Gore at Pharmapack 2020 in Paris, France, 5 & 6 February, Stand A96 at the Paris Expo, Porte de Versailles


Gore at PepTalk 2020

January 20, 2020 - January 24, 2020

Visit Gore at PepTalk 2020 in San Diego, CA USA January 20-24 at Stand 423 at the Hilton San Diego Bayfront

Press Release

Mayo Clinic, W. L. Gore & Associates Announce Avobis Bio, a Joint Venture for New Regenerative Therapies

Posted December 10, 2019

Mayo Clinic and W. L. Gore & Associates Inc., a global materials science company, have formed a joint venture to advance the development of implantable cell therapies to treat debilitating conditions with no cure.

Press Release

Gore Receives CE Mark for the GORE® CARDIOFORM ASD Occluder for the Treatment of Atrial Septal Defects in Europe

Posted October 2, 2019

W. L. Gore & Associates has introduced the newest member of its family of occluders, the GORE® CARDIOFORM ASD Occluder, which has received CE Mark. The device offers physicians a clinically proven design in a device that, in a recent study, met its primary endpoint for the percutaneous, transcatheter closure of ostium secundum atrial defects (ASDs).

Press Release

GORE® ENFORM Biomaterial Earns Innovative Technology Designation from Vizient, Inc.

Posted July 17, 2019

W. L. Gore & Associates announced that GORE® ENFORM Biomaterial for use in abdominal wall reconstruction procedures recently received the Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the U.S.

Featured Story

Gore Tackles Tough Biopharma Challenge

Posted July 11, 2019

Have you ever dropped your new phone and cracked the screen? It’s never a good feeling to lose something of value. Now imagine if that something was worth thousands to millions of dollars and had the potential to change lives. That’s what drug manufacturers stand to lose if a single-use bulk drug storage bag — holding biologic substances — is damaged. A new solution from Gore addresses this issue.

Press Release

First U.S. Patient Receives GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

Posted July 10, 2019

Gore announces the first U.S. implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. This first case follows the recent FDA approval for this new device.


Article: Expanding the Scope of Single-Use Technologies

Posted July 2, 2019

Single-use systems increasingly need to withstand the rigors of cold chain handling at -40°C to -80°C, particularly for packaging valuable bulk drug product for shipment. Read the article in Genetic Engineering to learn more about how Gore is helping to advance single-use technology in the pharmaceutical space.

Load more news